National Bank Of Canada Moon Lake Immunotherapeutics Transaction History
National Bank Of Canada
- $73.7 Billion
- Q4 2024
A detailed history of National Bank Of Canada transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, National Bank Of Canada holds 2 shares of MLTX stock, worth $84. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2Holding current value
$84% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MLTX
# of Institutions
136Shares Held
58.1MCall Options Held
124KPut Options Held
96.9K-
Bvf Inc San Francisco, CA19.8MShares$836 Million39.28% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$360 Million35.64% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.34MShares$142 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$117 Million2.15% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.19MShares$92.6 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.56B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...